• Je něco špatně v tomto záznamu ?

Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background

Kalousová M., Zima T., Tesař V., Dusilová-Sulková S., Škrha J.

. 2005 ; 579 (1-2) : 37-46.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07507100

Several diseases (atherosclerosis, diabetes mellitus, chronic renal failure) are associated with oxidative and carbonyl stress, microinflammation and eventually autoimmune reaction. Both oxidative and carbonyl stress cause damage to important biological structures-proteins, carbohydrates, lipids and nucleic acids and may enhance inflammatory response. New compounds and modified structures are formed, among them advanced oxidation protein products (AOPP), advanced glycation end products (AGEs-e.g. pentosidine, carboxymethyllysine) and advanced lipoperoxidation end products (ALEs). Accumulation of glycoxidation products, upregulation of protective mechanisms like glyoxalase I as well as enhanced transcription of genes coding for cytokines, growth factors and adhesive molecules via AGE-RAGE (receptor for AGEs) interaction and subsequent increase of classical acute phase reactants (e.g. CRP-C-reactive protein or orosomucoid) can be observed in a variety of chronic diseases. Additionally, several RAGE gene polymorphisms have shown association with some pathological states-diabetic complications, vascular damage, inflammatory response or antioxidant status. Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.

000      
03915naa 2200505 a 4500
001      
bmc07507100
003      
CZ-PrNML
005      
20120118090216.0
008      
080729s2005 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kalousová, Marta, $d 1974- $7 mzk2005318016
245    10
$a Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background / $c Kalousová M., Zima T., Tesař V., Dusilová-Sulková S., Škrha J.
314    __
$a Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Katerinská 32, 12108 Prague 2, Czech Republic. marta.kalousova@seznam.cz
520    9_
$a Several diseases (atherosclerosis, diabetes mellitus, chronic renal failure) are associated with oxidative and carbonyl stress, microinflammation and eventually autoimmune reaction. Both oxidative and carbonyl stress cause damage to important biological structures-proteins, carbohydrates, lipids and nucleic acids and may enhance inflammatory response. New compounds and modified structures are formed, among them advanced oxidation protein products (AOPP), advanced glycation end products (AGEs-e.g. pentosidine, carboxymethyllysine) and advanced lipoperoxidation end products (ALEs). Accumulation of glycoxidation products, upregulation of protective mechanisms like glyoxalase I as well as enhanced transcription of genes coding for cytokines, growth factors and adhesive molecules via AGE-RAGE (receptor for AGEs) interaction and subsequent increase of classical acute phase reactants (e.g. CRP-C-reactive protein or orosomucoid) can be observed in a variety of chronic diseases. Additionally, several RAGE gene polymorphisms have shown association with some pathological states-diabetic complications, vascular damage, inflammatory response or antioxidant status. Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.
650    _2
$a klinická chemie $x metody $7 D002624
650    _2
$a chronická nemoc $7 D002908
650    _2
$a produkty pokročilé glykace $x analýza $x metabolismus $7 D017127
650    _2
$a mitogenem aktivované proteinkinasy $x genetika $x metabolismus $7 D020928
650    _2
$a diabetes mellitus $x genetika $x metabolismus $7 D003920
650    _2
$a zánět $x etiologie $7 D007249
650    _2
$a chronické selhání ledvin $x komplikace $x metabolismus $7 D007676
650    _2
$a laktoylglutathionlyasa $x genetika $x metabolismus $7 D007791
650    _2
$a nukleotidy $x metabolismus $7 D009711
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a oxidační stres $7 D018384
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a receptory cytoplazmatické a nukleární $x metabolismus $7 D018160
650    _2
$a lidé $7 D006801
650    _2
$a financování organizované $7 D005381
700    1_
$a Zima, Tomáš, $d 1966- $7 jn20000620440
700    1_
$a Tesař, Vladimír, $d 1957- $7 jn20000402349
700    1_
$a Sulková, Sylvie, $d 1954- $7 jn20000710614
700    1_
$a Škrha, Jan, $d 1954- $7 jn99240001641
773    0_
$w MED00003430 $t Mutation research. [All sections] $g Roč. 579, č. 1-2 (2005), s. 37-46 $x 0027-5107
910    __
$a ABA008 $b B 1575 $y 9
990    __
$a 20080721085927 $b ABA008
991    __
$a 20120118090203 $b ABA008
999    __
$a ok $b bmc $g 622708 $s 475141
BAS    __
$a 3
BMC    __
$a 2005 $b 579 $c 1-2 $d 37-46 $i 0027-5107 $m Mutation research $x MED00003430
LZP    __
$a 2008-Doreen

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...